GO
| HSI1 | 25,335.95 | +272.24 | 350.93B |
| HSCEI1 | 8,582.74 | +83.21 | 156.54B |
| Back Zoom + Zoom - Block Traded | |
|
CSPC PHARMA Extends Gains to ~3%; 2025 Rev. Drops 10.4%, but Final DPS Added
2026-03-25 13:05:59 CSPC PHARMA (01093.HK) closed up 1% at midday. The Group announced at noon that its 2025 profit fell by 10.3%, but it increased its final dividend. The stock’s gains expanded in the afternoon session. It last printed at $8.57, jumping up 2.88%, with a trading volume of 54.0849 million shares, involving $460 million. CSPC PHARMA reported a revenue of RMB26.006 billion, down 10.4% YoY. Profit attributable to shareholders was RMB3.882 billion, down 10.3% YoY, with an EPS of RMB0.3398. A final DPS of $0.15 was declared, compared to $0.10 in the same period last year. Including the interim DPS of $0.14, the total annual DPS was $0.29, up 11.5% YoY. ~ AAStocks Financial News Website: www.aastocks.com | |